…
CuraScientific Corp. engages in the manufacturing, distribution, and sale of cannabis products under the JW Brands and Chad Enterprises brand names. It offers cannabidiol, kava, and kratom. The company was formerly known as Boon Industries, Inc. and changed its name to CuraScientific Corp. in April 2023. CuraScientific Corp. was incorporated in 2020 and is based in Coachella, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
CuraScientific Corp. (CSTF.US) is quoted on the OTC Pink market and public filings and disclosures provide few verifiable details about its operations, products, or target markets. Because available information is sparse, material long-term growth drivers cannot be reliably identified, though some investors may be attracted by typical microcap upside if the company clarifies strategy and delivers regular, audited reporting.
The most important investment risks are lack of transparent, up-to-date disclosures, very low liquidity, high potential for share dilution, and general financial and regulatory uncertainty common to OTC Pink listings.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | 33.70M | -5.27M | -5.87M | -4.86M | - |
| Net income | 33.70M | -5.27M | -5.87M | -4.86M | - |
| Selling general administrative | 2.10M | 1.79M | 4.22M | 2.19M | - |
| Gross profit | 0.48M | 0.02M | 0.06M | 0.04M | - |
| Reconciled depreciation | 0.02M | 0.62M | 0.61M | 0.39M | - |
| Ebit | - | -3.97M | -6.80M | -2.71M | -0.02M |
| Ebitda | - | -3.35M | -6.19M | -2.33M | - |
| Depreciation and amortization | - | 0.62M | 0.61M | 0.39M | - |
| Operating income | -2.89M | -2.38M | -4.78M | -2.53M | - |
| Other operating expenses | - | 2.41M | 4.86M | 2.59M | 0.38M |
| Interest expense | 0.20M | 1.22M | 1.16M | 0.37M | - |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | - |
| Net interest income | -0.20M | -1.22M | -1.16M | -0.37M | - |
| Income tax expense | - | -0.37M | -0.87M | 0.19M | - |
| Total revenue | 1.05M | 0.03M | 0.09M | 0.06M | - |
| Total operating expenses | 3.95M | 2.40M | 4.83M | 2.57M | - |
| Cost of revenue | 0.58M | 0.01M | 0.03M | 0.02M | - |
| Total other income expense net | 36.79M | -1.67M | 0.06M | -1.96M | - |
| Net income from continuing ops | 33.70M | -5.27M | -5.87M | -4.86M | - |
| Net income applicable to common shares | - | -5.27M | -5.87M | -4.86M | -0.47M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 1.55M | 2.24M | 2.73M | - | 0.12M |
| Intangible assets | 1.43M | 2.02M | 2.62M | - | - |
| Other current assets | 0.04M | 0.08M | 0.00M | - | - |
| Total liab | 71.06M | 71.63M | 199.43M | - | 0.12M |
| Total stockholder equity | -69.51M | -69.39M | -196.70M | - | 0.00M |
| Other current liab | 67.84M | 70.45M | 198.86M | 0.43M | - |
| Common stock | 0.33M | 0.04M | 0.00M | - | - |
| Capital stock | 0.33M | 0.04M | 0.00M | - | - |
| Retained earnings | -16.45M | -11.19M | -5.32M | -0.45M | 0.00M |
| Other liab | 0.25M | - | - | - | - |
| Cash | 0.00M | 0.02M | 0.01M | - | 0.00M |
| Total current liabilities | 70.81M | 71.63M | 199.43M | 0.57M | - |
| Current deferred revenue | 0.19M | 0.14M | 0.06M | - | - |
| Net debt | 2.64M | 1.04M | 0.43M | - | 0.11M |
| Short term debt | 2.64M | 1.06M | 0.44M | - | - |
| Short long term debt | 2.64M | 1.06M | 0.44M | - | - |
| Short long term debt total | 2.64M | 1.06M | 0.44M | - | 0.12M |
| Other stockholder equity | -53.39M | -58.24M | -191.39M | -0.01M | - |
| Property plant equipment | 0.09M | 0.09M | 0.09M | 0.10M | - |
| Total current assets | 0.04M | 0.13M | 0.01M | 0.00M | 0.00M |
| Net tangible assets | -71.83M | -71.66M | -199.32M | -0.47M | - |
| Net receivables | 0.00M | 0.02M | 0.00M | - | - |
| Inventory | 0.00M | 0.01M | 0.01M | - | - |
| Accounts payable | 0.33M | 0.11M | 0.14M | - | - |
| Non current assets total | 1.51M | 2.11M | 2.72M | - | 0.12M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | -0.02M | -0.01M | -0.01M | 0.00M | - |
| Change to liabilities | - | 0.20M | -0.02M | 0.14M | 0.00M |
| Total cashflows from investing activities | - | -0.01M | -0.01M | -0.01M | -0.01M |
| Net borrowings | - | 0.25M | 0.61M | 0.12M | 0.26M |
| Total cash from financing activities | 0.37M | 0.25M | 0.58M | 0.44M | 0.26M |
| Change to operating activities | - | 0.48M | 0.47M | 0.03M | 0.01M |
| Net income | 33.70M | -5.27M | -5.87M | -4.86M | -0.47M |
| Change in cash | 0.04M | -0.02M | 0.02M | 0.00M | -0.00M |
| Begin period cash flow | 0.00M | 0.02M | 0.01M | 0.00M | - |
| End period cash flow | 0.04M | 0.00M | 0.02M | 0.01M | 0.00M |
| Total cash from operating activities | -0.30M | -0.25M | -0.55M | -0.43M | -0.27M |
| Depreciation | 0.02M | 0.62M | 0.61M | 0.39M | 0.01M |
| Change to inventory | 0.07M | 0.01M | -0.00M | -0.01M | -0.01M |
| Change to account receivables | 0.02M | 0.04M | -0.02M | -0.02M | -0.02M |
| Other cashflows from financing activities | - | -0.01M | 0.58M | 0.44M | 0.31M |
| Change to netincome | - | 3.06M | 3.77M | 3.56M | 0.00M |
| Capital expenditures | 0.15M | 0.01M | 0.01M | 0.01M | 0.01M |
| Change in working capital | 0.54M | 0.72M | 0.43M | 0.16M | - |
| Stock based compensation | 0.63M | 0.47M | 3.30M | 1.60M | - |
| Other non cash items | -39.67M | 3.20M | 0.97M | 2.29M | - |
| Free cash flow | -0.45M | -0.27M | -0.56M | -0.43M | - |
Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CSTF CuraScientific Corp. |
- -% |
0.00 | - | - | 0.36 | - | 1.02 | 0.03 |
| MKKGY Merck KGaA ADR |
-0.68 2.09% |
31.83 | 21.25 | 14.93 | 3.10 | 2.14 | 3.60 | 12.98 |
| MKGAF MERCK Kommanditgesellschaft auf Aktien |
- -% |
163.45 | 24.86 | 15.11 | 3.13 | 1.98 | 3.08 | 18.89 |
| TAK Takeda Pharmaceutical Co Ltd ADR |
0.38 1.77% |
21.79 | - | 10.96 | 0.01 | 1.20 | 2.94 | 23.11 |
| TKPHF Takeda Pharmaceutical Co. Ltd. |
- -% |
43.05 | - | 10.66 | 0.01 | 1.16 | 2.94 | 23.11 |
CuraScientific Corp. engages in the manufacturing, distribution, and sale of cannabis products under the JW Brands and Chad Enterprises brand names. It offers cannabidiol, kava, and kratom. The company was formerly known as Boon Industries, Inc. and changed its name to CuraScientific Corp. in April 2023. CuraScientific Corp. was incorporated in 2020 and is based in Coachella, California.
51544 Cesar Chavez Street, Coachella, CA, United States, 92236
909 435 1642
2
| Name | Title | Year Born |
|---|---|---|
| Mr. Justin Gonzalez | Chief Operating Officer | 1981 |
| Mr. Johann Loewen | Chief Revenue Officer | 1976 |
| Mr. Samuel L. Berry | CEO, President, Secretary & Interim Chairman of the Board | 1979 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.